Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Pharnext, SAS
ClinicalTrials.gov Identifier:
NCT01401257
First received: July 20, 2011
Last updated: September 11, 2013
Last verified: July 2011